Journal of Gastrointestinal Surgery

, Volume 19, Issue 8, pp 1522–1527 | Cite as

Variations in Metastasis Site by Primary Location in Colon Cancer

  • Ramzi Amri
  • Liliana G. Bordeianou
  • Patricia Sylla
  • David L. BergerEmail author
Original Article



The purpose of this paper is to determine whether sites of distant recurrence are associated with specific locations of primary disease in colon cancer.


A cohort including all patients (n = 947) undergoing a segmental colonic resection for colon cancer at our center (2004–2011) comparing site-specific metastatic presentation and recurrence rates, as well as their respective multivariable American Joint Committee on Cancer (AJCC) stage-adjusted hazard ratios (mHR).


Right-sided colectomies (n = 557) had a lower overall metastasis rate (24.8 % vs. 31.8 %; P = 0.017; mHR = 1.24 [95% CI: 0.96–1.60]; P = 0.011) due to significantly lower pulmonary metastasis in follow-up (2.7 % vs. 9 %; P < 0.001; mHR = 0.32 [95% CI: 0.17–0.58]; P = 0.001) and lower overall liver metastasis rate (15.6 vs. 22.1 %; P = 0.012; mHR = 0.74 [95% CI: 0.55–0.99];P = 0.050). Left colectomies (n = 127) had higher rates of liver metastasis during follow-up (9.4 % vs. 4.8 %; P = 0.029; mHR = 1.64 [95% CI: 0.86–3.15]; P = 0.134). Sigmoid resections (n = 238) had higher baseline rates of liver metastasis (17.1 % vs. 11.3 %; P = 0.015) and higher cumulative rates of lung (12.2 % vs. 5.4 %; P < 0.001; mHR = 2.26 [95 % CI: 1.41–3.63]; P = 0.001) and brain metastases (2.3 % vs. 0.6 %; P = 0.033; mHR = 4.03 [95% CI: 1.14–14.3]; P = 0.031). Other sites of metastasis, including the (retro) peritoneum, omentum, ovary, and bone, did not yield significant differences.


Important variations in site-specific rates of metastatic disease exist within major resection regions of colon cancer. These variations may be important to consider when evaluating options for adjuvant treatment and surveillance after resection of the primary disease.


Colon cancer Metastasis site Metastatic patterns Outcomes Primary disease site 


Conflicts of Interest

None of the authors have conflicts of interest. DB had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Funding and support

This work was conducted with support from the Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05, and financial contributions from the Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University, and its affiliated academic health care centers, or the National Institutes of Health.


  1. 1.
    Kindler HL, Shulman KL. Metastatic colorectal cancer. Curr Treat Options in Oncol. 2001;2(6):459–471.CrossRefGoogle Scholar
  2. 2.
    Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastastic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150(3):195–203.PubMedCrossRefGoogle Scholar
  3. 3.
    Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–117.PubMedCrossRefGoogle Scholar
  4. 4.
    Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology. 2007;73(1–2):52–57.PubMedCrossRefGoogle Scholar
  5. 5.
    Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer. 1980;45(12):2969–2974.PubMedCrossRefGoogle Scholar
  6. 6.
    Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101(5):403–408.PubMedCrossRefGoogle Scholar
  7. 7.
    Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer?—a systematic review. Eur J Surg Oncol. 2015;41(3):300–308.PubMedCrossRefGoogle Scholar
  8. 8.
    Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53(1):57–64.PubMedCrossRefGoogle Scholar
  9. 9.
    Moritani K, Hasegawa H, Okabayashi K, Ishii Y, Endo T, Kitagawa Y. Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution. Surg Today. 2014;44(9):1685–1691.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Tuppurainen K, Mäkinen JM, Junttila O, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol. 2005;207(3):285–294.PubMedCrossRefGoogle Scholar
  11. 11.
    Hugen N, van de Velde CJH, de Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651–657.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Sun C, Zargham R, Shao Q, et al. Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer. Pathol Res Pract. 2014;210(10):668–674.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2015

Authors and Affiliations

  • Ramzi Amri
    • 1
  • Liliana G. Bordeianou
    • 1
  • Patricia Sylla
    • 2
  • David L. Berger
    • 1
    Email author
  1. 1.Division of General and Gastrointestinal SurgeryMassachusetts General Hospital and Harvard Medical SchoolBostonUSA
  2. 2.Department of Colon and Rectal SurgeryIcahn School of Medicine, Mount Sinai HospitalNew YorkUSA

Personalised recommendations